Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Flare up reaction during provocation test to glatiramer acetate in a patient with allergy to interferon beta1a.
Isolated cognitive relapses in multiple sclerosis.
POLG mutations associated with remitting/relapsing neurological events.
Organic Causes of Erectile Dysfunction in Men Under 40.
Activated Human CD4+CD45RO+ Memory T-Cells Indirectly Inhibit NLRP3 Inflammasome Activation through Downregulation of P2X7R Signalling.
Magnetic resonance imaging characterization of different experimental autoimmune encephalomyelitis models and the therapeutic effect of glatiramer acetate.
Modulators of the Sphingosine 1-phosphate receptor 1.
Thalamic-hippocampal-prefrontal disruption in relapsing-remitting multiple sclerosis.
Behavioral experiences as drivers of oligodendrocyte lineage dynamics and myelin plasticity.
Medical and pharmacy claims-based algorithims for identifying patients with multiple sclerosis.
Novel MRI and PET markers of neuroinflammation in multiple sclerosis.
EBV-Associated Cancer and Autoimmunity: Searching for Therapies.
Neuro-ophthalmology update.
Impaired Cerebrovascular Reactivity in Multiple Sclerosis.
Incidence of Multiple Sclerosis and Related Disorders in Asian Populations of British Columbia.
Epoch Analysis of On-Treatment Disability Progression Events over Time in the Tysabri Observational Program (TOP).
Is It Too Early to Predict the Failure of Natalizumab in NMO?-Reply.
Nurr1 reduction influences the onset of chronic EAE in mice.
Bringing CLARITY to gray matter atrophy.
Status migrainosus as an initial presentation of multiple sclerosis.
Ambulation and multiple sclerosis.
Possible Role of Staphylococcal Enterotoxin B in the Pathogenesis of Autoimmune Diseases.
Can a physician predict the clinical response to first-line immunomodulatory treatment in relapsing-remitting multiple sclerosis?
Lymphomatosis cerebri Presenting as a Recurrent Leukoencephalopathy.
Effect of vibration stimulation on dysbasia of spastic paraplegia in neuromyelitis optica: a possible example of neuronal plasticity.
Pages
« first
‹ previous
…
376
377
378
379
380
381
382
383
384
…
next ›
last »